M&T Bank Corp lifted its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 23.4% in the fourth ...

Meanwhile, the pharmacological pipeline for Tourette's is thin, with disappointing results for Teva's deutetrabenazine and Neurocrine Bio's Ingrezza (valbenazine) in phase 3 trials. At the moment ...

Here are the top phones from Apple, Google, Samsung and others that we've tested for T-Mobile, including those you need to access the fastest network speeds. I’m one of PCMag’s mobile analysts.

Competition to Austedo and Xenazine is also looming from Neurocrine Biosciences, whose VMAT2 drug Ingrezza (valbenazine) is already approved to treat tardive dyskinesia with a phase 3 readout in ...

After hours: March 13 at 7:59:52 PM EDT Loading Chart for T ...

Health care systems that adopted a higher volume of telehealth services less frequently used several low-value screening and diagnostic tests, according to results of a cohort study published in ...

has dosing that's always one pill, once daily. and you can keep taking most mental health meds. ingrezza can cause depression, suicidal thoughts, or actions in patients with huntington's disease. call ...

* Between subway hours and Owl service, use the T Bus. See below for detailed schedule information and live data.